What is the management approach for congenital muscular dystrophy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 3, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management Approach for Congenital Muscular Dystrophy

The management of congenital muscular dystrophy (CMD) requires a multidisciplinary care team with coordinated interventions focusing on anticipatory and preventive measures to improve quality of life, function, and longevity. 1, 2

Diagnostic Considerations

  • Precise genetic diagnosis is essential and should be actively sought in all cases
  • Initial screening with creatine kinase (CK) levels
  • Confirmatory testing through:
    • Genetic testing for specific CMD-related mutations
    • Muscle biopsy when genetic testing is inconclusive

Core Management Components

Neuromuscular Management

  • Regular assessment of function, strength, and range of motion at least every 6 months 3
  • Glucocorticoid therapy consideration based on specific CMD subtype and clinical progression
  • Complete immunization schedule to prevent respiratory complications

Rehabilitation Management

  • Preventive measures to maintain muscle extensibility and minimize contractures
  • Appropriate exercise and activity encouragement within tolerance limits
  • Provision of adaptive devices as needed for mobility and function
  • Regular podiatry assessment to prevent foot complications 4
  • Custom orthotic insoles to improve biomechanics and reduce pressure points

Respiratory Care

  • Regular pulmonary function monitoring
  • Early introduction of cough assistance techniques
  • Discussion about mechanical ventilation options before need becomes urgent 3
  • Prompt treatment of respiratory infections

Cardiac Management

  • Echocardiogram at diagnosis and regular follow-up (every 1-2 years) 3
  • ACE inhibitors as first-line therapy for cardiac involvement
  • Beta-blockers may be added based on cardiac function
  • Consider angiotensin receptor blockers (ARBs) if ACE inhibitors not tolerated 4

Orthopedic Management

  • Monitoring for scoliosis and joint contractures
  • Consideration of surgical options for contractures in specific situations
  • Proper wheelchair positioning with appropriate foot support
  • Interventions for foot position to prevent deformities

Gastrointestinal/Nutritional Management

  • Regular monitoring of weight gain
  • Nutritional assessment for both underweight and overweight concerns
  • Attention to potential swallowing difficulties
  • Dietary modifications as needed

Psychosocial Support

  • Family support and early intervention for developmental concerns
  • Assessment and intervention for learning, behavior, and coping
  • Promotion of independence and social development
  • Educational support through individualized education programs

End-of-Life Care Considerations

  • Palliative care for pain management and emotional support
  • Hospice care when appropriate for end-stage patients 3
  • Advance care planning discussions with patient and family

Transition Planning

  • Preparation for transition to adult services
  • Development of educational and vocational opportunities
  • Encouraging self-advocacy in medical care 3

Common Pitfalls to Avoid

  • Delaying genetic diagnosis, which may impact eligibility for emerging mutation-specific therapies
  • Underestimating quality of life in patients with advanced disease
  • Failing to discuss mechanical ventilation options early in disease course
  • Not recognizing the importance of multidisciplinary care coordination
  • Overlooking psychosocial aspects of care, which are central to management

The management of CMD requires ongoing coordination between neurology, pulmonology, cardiology, orthopedics, rehabilitation, nutrition, and psychosocial services to address the multisystem nature of the disease and optimize patient outcomes.

References

Research

Congenital muscular dystrophies.

Handbook of clinical neurology, 2013

Research

Congenital muscular dystrophies: What is new?

Neuromuscular disorders : NMD, 2021

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Foot Swelling in Muscular Dystrophy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.